Fecal Pancreatic Elastase Testing Market, Global Outlook and Forecast 2023-2028

Report ID: 1734868 | Published Date: Jan 2025 | No. of Page: 68 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story

Fecal pancreatic elastase testing is a kind of test that measures the amount of elastase in the stool. The demand for fecal pancreatic elastase testing is increasing globally due to rising prevalence of exocrine pancreatic insufficiency (EPI).
This report contains market size and forecasts of Fecal Pancreatic Elastase Testing in Global, including the following market information:
Global Fecal Pancreatic Elastase Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fecal Pancreatic Elastase Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fecal Pancreatic Elastase ELISA Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fecal Pancreatic Elastase Testing include Labcorp, DiaSorin, ScheBo Biotech AG, Immundiagnostik AG, Invivo Healthcare, DRG Instruments GMBH, Verisana Laboratories, BÜHLMANN Laboratories AG and CerTest Biotec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fecal Pancreatic Elastase Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fecal Pancreatic Elastase Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fecal Pancreatic Elastase Testing Market Segment Percentages, by Type, 2021 (%)
Fecal Pancreatic Elastase ELISA Kits
Rapid Fecal Pancreatic Elastase Kits
Global Fecal Pancreatic Elastase Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fecal Pancreatic Elastase Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostics Laboratories
Specialty Clinics
Global Fecal Pancreatic Elastase Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fecal Pancreatic Elastase Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fecal Pancreatic Elastase Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fecal Pancreatic Elastase Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Labcorp
DiaSorin
ScheBo Biotech AG
Immundiagnostik AG
Invivo Healthcare
DRG Instruments GMBH
Verisana Laboratories
BÜHLMANN Laboratories AG
CerTest Biotec
R-Biopharm AG
Vitassay Healthcare

Frequently Asked Questions
Fecal Pancreatic Elastase Testing Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Fecal Pancreatic Elastase Testing Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Fecal Pancreatic Elastase Testing Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports